Zdrowie i gospodarka · 06/05/2026
Prospective Grant of an Exclusive Patent License: Development and Commercialization of Engineered Cell Therapies for the Treatment of Cancer
The National Cancer Institute is considering granting an Exclusive Patent License to OncoVanta Therapeutics, Inc. for the development and commercialization of engineered cell therapies for cancer treatment.